🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

19 Most Recommended High Yield Large Cap Stocks

Published 06/18/2012, 03:31 AM
Updated 07/09/2023, 06:31 AM
GSK
-

952! That’s the number of stocks with a dividend yield over 5 percent, also called High Yields. Those stocks can give you a huge income boost if the dividend payments are sustainable. Let’s take a look at the stocks with the highest recommendation level.

I screened all high yields at the capital markets with a buy or better recommendation and a market capitalization over USD 10 billion. Nineteen stocks remained of which four have a double-digit yield.

Plains All American Pipelines (NYSE:PAA) has a market capitalization of $12.38 billion. The company employs 3,800 people, generates revenues of $34,275.00 million and has a net income of $994.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,530.00 million. Because of these figures, the EBITDA margin is 4.46 percent (operating margin 3.79 percent and the net profit margin finally 2.90 percent).

Financial Analysis: The total debt representing 33.80 percent of the company’s assets and the total debt in relation to the equity amounts to 95.39 percent. Due to the financial situation, a return on equity of 15.47 percent was realized. Twelve trailing months earnings per share reached a value of $5.01. Last fiscal year, the company paid $3.91 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.31, P/S ratio 0.36 and P/B ratio 2.27. Dividend Yield: 5.45 percent. The beta ratio is 0.49.

Long-Term Stock History Chart Of Plains All Americ

Long-Term Dividends History of Plains All Americ... (PAA)

Long-Term Dividend Yield History of Plains All Americ... (NYSE PAA)
Enterprise Products (NYSE:EPD) has a market capitalization of $42.68 billion. The company employs 6,900 people, generates revenues of $44,313.00 million and has a net income of $2,088.30 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,736.30 million. Because of these figures, the EBITDA margin is 8.43 percent (operating margin 6.45 percent and the net profit margin finally 4.71 percent). 

Financial Analysis: The total debt representing 42.58 percent of the company’s assets and the total debt in relation to the equity amounts to 119.94 percent. Due to the financial situation, a return on equity of 17.43 percent was realized. Twelve trailing months earnings per share reached a value of $2.61. Last fiscal year, the company paid $2.44 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.30, P/S ratio 0.96 and P/B ratio 3.51. Dividend Yield: 5.25 percent. The beta ratio is 0.60.

Long-Term Stock History Chart Of Enterprise Produc

Long-Term Dividends History of Enterprise Produc... (EPD)

Long-Term Dividend Yield History of Enterprise Produc... (NYSE EPD)
GlaxoSmithKline (NYSE:GSK) has a market capitalization of $111.82 billion. The company employs 97,389 people, generates revenues of $43,038.99 million and has a net income of $8,577.31 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,470.48 million. Because of these figures, the EBITDA margin is 33.62 percent (operating margin 28.50 percent and the net profit margin finally 19.93 percent).

Financial Analysis: The total debt representing 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.15. Last fiscal year, the company paid $2.20 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.33, P/S ratio 2.61 and P/B ratio 9.01. Dividend Yield: 5.05 percent. The beta ratio is 0.63.

Long-Term Stock History Chart Of GlaxoSmithKline p

Long-Term Dividends History of GlaxoSmithKline p... (GSK)

Long-Term Dividend Yield History of GlaxoSmithKline p... (NYSE GSK)
Take a closer look at the full table of high yield large cap stocks with buy or better recommendation. The average price to earnings ratio (P/E ratio) amounts to 16.13 and forward P/E ratio is 9.61. The dividend yield has a value of 7.91 percent. Price to book ratio is 2.17 and price to sales ratio 1.56. The operating margin amounts to 16.95 percent and the beta ratio is 1.02.

Here is the full table with some fundamentals (TTM):

19 Most Recommended High Yield Large Caps
Related stock ticker symbols:
TEF, FTE, AGNC, STD, CTL, TOT, CIG, E, SLF, ETE, TI, WPZ, MBT, VIP, PAA, VOD, EPD, MT, GSK

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.